Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2025-09-24 19:22:17| BBC News | Business | World Edition

Sales of new homes in the US surge more than expected as builders offered their discounts to lure in buyers.


Category: News and Media

 

LATEST NEWS

2025-09-24 18:37:31| The Economic Times

Promoters of Polycab India are expected to sell up to 0.81% stake through block deals, setting a floor price of Rs 7,300 per share to potentially raise Rs 887.6 crore. Several promoters, including Inder T. Jaisinghani, will participate in the sale, following a recent dip in Polycab's share price after hitting a 52-week high.


Category: News and Media

 

2025-09-24 18:32:11| Chicago Tribune news - Business

Brookbank and his wife paid $1 million in 2012 for the brick house, which was built in 2007 and is on North Bell Avenue.


Category: News and Media

 

Latest from this category

25.09Pharma, healthcare firms eye Rs 13,000-cr IPO wave over 9 months
25.09Bonds languish as market awaits borrowing plan, MPC review
25.09Continuum Green to acquire remaining 26% stake from CEIL
25.09Real estate stocks decline amid sluggish demand concerns
25.09Are constant maturity index funds a better bet than short-term bank deposits?
25.09Domestic equity markets decline for fourth straight session amid H-1B visa concerns
25.09Labubu dolls made up 90% of fake toys seized at UK border
25.09UK drug price rises 'necessary', says Patrick Vallance
News and Media »

All news

25.09Pharma, healthcare firms eye Rs 13,000-cr IPO wave over 9 months
25.09Bonds languish as market awaits borrowing plan, MPC review
25.09Continuum Green to acquire remaining 26% stake from CEIL
25.09Real estate stocks decline amid sluggish demand concerns
25.09Are constant maturity index funds a better bet than short-term bank deposits?
25.09Domestic equity markets decline for fourth straight session amid H-1B visa concerns
25.09Labubu dolls made up 90% of fake toys seized at UK border
25.09UK drug price rises 'necessary', says Patrick Vallance
More »
Privacy policy . Copyright . Contact form .